Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001415889-25-015971

Director acquired 5,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BIENAIME JEAN JACQUES Director 2025-06-04 Grant or award +5,250 5,450 D
Derivatives
BIENAIME JEAN JACQUES Director 2025-06-04 Grant or award · Stock Option (right to buy) +10,500 10,500 D
Loading xslF345X05/form4-06062025_040601.xml…